The State Pharmaceuticals Manufacturing Corporation (SPMC) yesterday launched locally-manufactured Clopidogrel 75mg under the ‘Aluth Ratata, Aluth Beheth’ program.
Clopidogrel is an anti-platelet medication used to reduce the risk of heart disease and stroke in high-risk patients. It is the second medication produced under the program, with Gabapentin 300mg released to the market in September. The program aims at reducing health sector costs to import drugs to the country by manufacturing required drugs within the country.
Speaking at the launching ceremony, State Minister of Production, Supply and Regulation of Pharmaceuticals Prof. Channa Jayasumana said that the country would be able to save nearly Rs 700 million as a result of producing this drug locally. “Under the concept of ‘New Drugs for a New Country,’ I would hand over the challenge of launching one drug per month next year and one drug for two weeks later next year to the SPMC.”
According to a statement issued by the Pharmaceutical Production, Supply and Regulation State Ministry, the State spends Rs. 317 million to import this particular drug annually, with the private sector spending Rs. 400 million. The SPMC will provide a pill for Rs. 2.10 to the Medical Supplies Division (MSD).
The Ministry added that a new drug will be launched every month under the program, with a drug launch every two weeks next year.